Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-15 @ 8:56 AM
Study NCT ID:
NCT00704366
Status:
COMPLETED
Last Update Posted:
2011-05-16
First Post:
2008-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D8180C00021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Mary Stuart, BSc MSc MB BCh BAO MRCPI, Medical Science Director Emerging Oncology Product Team 1
Old Organization:
AstraZeneca Pharmaceuticals